Modulation of MK-801-elicited mouse popping behavior by galantamine is complex and dose-dependent

This publication has 13 references indexed in Scilit:

• Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer’s disease
  Biological Psychiatry, 2001
• A Revised Excitotoxic Hypothesis of Schizophrenia: Therapeutic Implications
  Clinical Neuropharmacology, 2001
• Decreased protein level of nicotinic receptor α7 subunit in the frontal cortex from schizophrenic brain
  NeuroReport, 1999
• The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
  Neuropsychopharmacology, 1999
• Chapter 28 The glutamate synapse in neuropsychiatric disorders: Focus on schizophrenia and Alzheimer's disease
  Published by Elsevier ,1998
• Choline is a Selective Agonist of α7 Nicotinic Acetylcholine Receptors in the Rat Brain Neurons
  European Journal of Neuroscience, 1997
• The Glutamatergic Dysfunction Hypothesis for Schizophrenia
  Harvard Review of Psychiatry, 1996
• Computerized Measurement of MK-801-Elicited Popping and Hyperactivity in Mice
  Clinical Neuropharmacology, 1995
• Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
  Biological Psychiatry, 1995
• A “Glutamatergic Hypothesis” of Schizophrenia
  Clinical Neuropharmacology, 1989